AI Verdict
IOR has stronger fundamentals based on our AI analysis.
IOVA vs IOR Fundamental Comparison
| Metric | IOVA | IOR |
|---|---|---|
| Revenue | $263.5M | $0.0 |
| Net Income | $-391.0M | $4.0M |
| Net Margin | -148.4% | N/A |
| ROE | -56.0% | 3.2% |
| ROA | -42.8% | 3.2% |
| Current Ratio | 3.20x | N/A |
| Debt/Equity | 0.00x | 0.08x |
| EPS | $-1.09 | $0.98 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOVA vs IOR: Frequently Asked Questions
Is IOVA or IOR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IOR has stronger fundamentals. IOVA is rated STRONG SELL (92% confidence) while IOR is rated SELL (75% confidence). This is not investment advice.
How does IOVA compare to IOR fundamentally?
IOVANCE BIOTHERAPEUTICS, INC. has ROE of -56.0% vs INCOME OPPORTUNITY REALTY INVESTORS INC /TX/'s 3.2%. Net margins are -148.4% vs N/A respectively.
Which stock pays higher dividends, IOVA or IOR?
IOVA has a dividend yield of N/A or no dividend while IOR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOVA or IOR for long term?
For long-term investing, consider that IOVA has STRONG SELL rating with 92% confidence, while IOR has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOVA vs IOR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOVA vs IOR, the AI consensus favors IOR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.